News - Global

Filter

Current filters:

Global

Popular Filters

226 to 250 of 328 results

Leading dopamine agonists will continue to dominate Parkinson's market

19-08-2012

The leading dopamine agonists, pramipexole (Boehringer Ingelheim's Mirapex/Mirapexin/Sifrol/BI-Sifrol,…

Boehringer IngelheimGlaxoSmithKlineGlobalMarkets & MarketingMirapexNeuproNeurologicalPharmaceuticalRequipRytaryUCB

AstraZeneca to get $250 million-plus from OTC Nexium deal with Pfizer

15-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says it has entered into an agreement with Pfizer (NYSE:…

AstraZenecaFinancialGastro-intestinalsGlobalLicensingNexiumPfizerPharmaceutical

World's first (official) biosimilar antibody goes to reumatoid arthritis

09-08-2012

The end of July 2012 proved exciting for the world of biosimilar manufacturers. However, for the regulatory…

BiotechnologyCellTrionGenericsGlobalinfliximabJohnson & JohnsonMarkets & MarketingRegulationRemicadeRemsima

Middle-income countries flex muscles to overcome patents in face of unaffordable drug prices

29-07-2012

Middle-income countries are increasingly taking measures to overcome the patents that price drugs out…

Anti-viralsGenericsGlobalPatentsPharmaceuticalPricing

The X Factor for life sciences in emerging markets

26-07-2012

In the last year, emerging countries have confirmed their status as major players in the global Life…

GlobalManagementPharmaceutical

Pharma industry calls for broad-based cooperation to fight on-line sales of counterfeit medicines

24-07-2012

The global pharmaceutical industry unveiled recommendations this week to tackle the growing public health…

BiotechnologyGenericsGlobalMarkets & MarketingPharmaceuticalRegulation

More than 150 ARVs available through PEPFAR for global HIV/AIDS relief

24-07-2012

US Food and Drug Administration Commissioner Margaret Hamburg says that the agency has approved or tentatively…

Anti-viralsGenericsGlobalPharmaceuticalRegulation

Merck & Co in-licenses Chimerix antiviral; Fiocruz to make ARVs in Africa

24-07-2012

USA-based Chimerix, a venture-funded biotech focused on developing novel oral antivirals, has announced…

Anti-viralsChimerixCMX001CMX157FiocruzGlobalLicensingMarkets & MarketingMerck & CoPharmaceuticalRest of the World

DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination

24-07-2012

Coinciding with the XIX International AIDS Conference in Washington DC, the Drugs for Neglected Diseases…

Anti-viralsCiplaGenericsGlobalPharmaceuticalResearch

Lilly/Boehringer Ingelheim's Cymbalta now fibromyalgia market leader in USA

22-07-2012

US drug major Eli Lilly (NYSE: LLY) and German independent Boehringer Ingelheim's Cymbalta (duloxetine)…

Boehringer IngelheimCymbaltaEli LillyGlobalLyricaMarkets & MarketingNeurologicalNorth AmericaPfizerPharmaceutical

Domestic HIV funding outpaces international investments

19-07-2012

A new report by the Joint United Nations Program on HIV/AIDS (UNAIDS) shows that domestic funding for…

Anti-viralsFinancialGlobalHealthcarePharmaceutical

Global medicines spending set to rebound, reaching nearly $1.2 trillion by 2016, says IMS

13-07-2012

Following several years of slowing growth, the global market for medicines is poised to rebound from…

BiotechnologyGenericsGlobalHealthcareMarkets & MarketingPatentsPharmaceutical

Pharma industry is using social media for DTC marketing

02-07-2012

A multi-billion dollar industry that is banned in all but the USA and New Zealand, direct-to-consumer…

GlobalMarkets & MarketingPharmaceutical

Intellectual property encourages collaboration, R&D in developing economies

21-06-2012

The USA-based Biotechnology Industry Organization (BIO) unveiled a report on the role of intellectual…

BiotechnologyGlobalPatentsPharmaceuticalResearch

Global asthma and COPD drug market to reach nearly $27 billion in 2017

19-06-2012

The global asthma and chronic obstructive pulmonary disease (COPD) market was worth $25.102 billion in…

GlobalMarkets & MarketingPharmaceuticalRespiratory and Pulmonary

Tomorrow's BioPharma landscape viewed by EvaluatePharma

19-06-2012

The quantity of biologic drugs on the market will likely soar by 2018, according to analysts at Evaluate…

BiotechnologyFinancialGlobalMarkets & MarketingResearch

Worldwide Rx drug sales forecast to grow to $885 billion by 2018

15-06-2012

The market for prescription drugs, based on the consensus forecast for the leading 500 pharmaceutical…

GlobalMarkets & MarketingNovartisPharmaceutical

More guidelines needed to grow regenerative medicine market, report finds

11-06-2012

Standardized research guidelines are needed to control and encourage the development of gene therapy…

BiotechnologyFinancialGlobalPoliticsRegulationResearch

Orexo and ProStrakan reconfigure rights to Abstral

04-06-2012

Sweden's Orexo AB (STO: ORX) and Scotland-based ProStrakan, a subsidiary of Japanese drugmaker Kyowa…

AbstralGlobalKyowa Hakko KirinLicensingOncologyOrexo ABPharmaceuticalProStrakan

Current pharma pricing policy will hurt both patients and industry in the long run, assert pharma experts

25-05-2012

Pharmaceutical analysts in India and the UK believe cost-based pricing is not suitable to safeguard the…

GenericsGlobalHealthcarePharmaceuticalPricing

Pharma sales force levels in China surpass USA for first time

24-05-2012

In the 12 months ending March 2012, sales force levels in China were up over 17% to 80,000 full time…

GlobalMarkets & MarketingPharmaceutical

226 to 250 of 328 results

Back to top